Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX
Conditions
- Congenital Bleeding Disorder
- Haemophilia A With Inhibitors
- Haemophilia B With Inhibitors
Interventions
- DRUG: activated recombinant human factor VII
- DRUG: Feiba VH
Sponsor
Novo Nordisk A/S